Loopbaan van Thomas Ryll
Eerdere bekende functies van Thomas Ryll
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| IMMUNOGEN, INC. | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 | 01-10-2021 |
| Corporate Officer/Principal | 01-08-2015 | - | |
| BIOGEN INC. | Corporate Officer/Principal | - | - |
Opleiding van Thomas Ryll
| Technische Universität Braunschweig | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 3 |
| Duitsland | 2 |
Operationeel
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology ImmunoGen, Inc. engages in the discovery and development of antibody-drug conjugates to improve outcomes for cancer patients. Its pipeline includes Mirvetuximab Soravtansine, IMGN632, IMGC936, and IMGN151. The company was founded on March 27, 1981 and is headquartered in Waltham, MA. | Health Technology |
- Beurs
- Insiders
- Thomas Ryll
- Ervaring
